Profile
Christopher D.
T.
Guiffre was the founder of Mercator Therapeutics, Inc. (2009) and served as President & Chief Executive Officer.
Current jobs include Chief Executive Officer at Pear Therapeutics, Inc. (2023), Member of the Massachusetts Bar Association, Chief Financial & Operating Officer at Pear Therapeutics (US), Inc. (2017), and President & Chief Operating Officer at Auron Therapeutics, Inc. (2023).
Former jobs include President & Chief Executive Officer at Alvos Therapeutics, Inc., Chief Executive Officer at Daré Bioscience, Inc. (2015-2017), VP, General Counsel & Director-Legal Affairs at Renaissance Worldwide, Inc. (1997-2001), Secretary, Senior Vice President & General Counsel at Cubist Pharmaceuticals LLC (2001-2008), Associate at BMC Partners LLP, Associate at Morgan, Lewis & Bockius LLP, Chief Business Officer at Hydra Biosciences, Inc., and Chief Operating Officer & Senior Vice President at Cerulean Pharma, Inc. (2014-2015).
Education includes an undergraduate degree from Babson College, a graduate degree from Boston College Law School, and an MBA from Wallace E Carroll School of Management.
Christopher Guiffre active positions
| Companies | Position | Start |
|---|---|---|
| PEAR THERAPEUTICS, INC. | Chief Executive Officer | 2023-04-05 |
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as lawyers association | Corporate Officer/Principal | - |
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications | Director of Finance/CFO | 2017-11-30 |
Auron Therapeutics, Inc.
Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | President | 2023-08-09 |
Former positions of Christopher Guiffre
| Companies | Position | End |
|---|---|---|
| DARÉ BIOSCIENCE, INC. | Chief Executive Officer | 2017-06-30 |
Mercator Therapeutics, Inc.
Mercator Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer drugs | Founder | 2012-04-10 |
| CUBIST PHARMACEUTICALS INC | General Counsel | 2008-04-29 |
Renaissance Worldwide, Inc.
Renaissance Worldwide, Inc. Information Technology ServicesTechnology Services Provides computer management and consulting services | General Counsel | 2000-12-31 |
Morgan, Lewis & Bockius LLP
Morgan, Lewis & Bockius LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Training of Christopher Guiffre
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Renaissance Worldwide, Inc.
Renaissance Worldwide, Inc. Information Technology ServicesTechnology Services Provides computer management and consulting services | Technology Services |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Mercator Therapeutics, Inc.
Mercator Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer drugs | Health Technology |
BMC Partners LLP
BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Morgan, Lewis & Bockius LLP
Morgan, Lewis & Bockius LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as lawyers association | Commercial Services |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
Alvos Therapeutics, Inc.
Alvos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer drugs | Health Technology |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wallace E Carroll School of Management
Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications | Technology Services |
Daré Bioscience, Inc.
Daré Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Auron Therapeutics, Inc.
Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | Commercial Services |
Pear Therapeutics, Inc.
Pear Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a commercial stage healthcare company that develops software based medicines | Technology Services |
- Stock Market
- Insiders
- Christopher Guiffre
















